Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vita Coco Company, Inc. (NASDAQ: COCO) files reports and disclosures with the U.S. Securities and Exchange Commission as part of its obligations as a public company. This page compiles those SEC filings and pairs them with AI-powered tools that help explain the information contained in key documents.
Through its filings, the company reports on topics such as quarterly and annual financial performance, business developments, and regulatory matters. Recent Form 8-K filings, for example, reference press releases announcing financial results for quarters ended June 30 and September 30, 2025, as well as a company statement regarding tariff relief affecting coconut water products. These filings provide detail on net sales, gross profit, net income, and non-GAAP measures like Adjusted EBITDA, along with management’s commentary on factors such as tariffs, costs, and demand for Vita Coco Coconut Water and related products.
On this page, users can access core documents such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K as they become available through EDGAR. AI-generated summaries are designed to highlight major themes, clarify technical language, and surface items that may matter to shareholders, such as segment performance, tariff discussions, or capital allocation programs mentioned in earnings releases.
In addition, this page provides convenient access to insider transaction reports on Form 4 and other ownership-related filings when they are filed. Together, these resources allow investors, analysts, and interested readers to review The Vita Coco Company’s regulatory disclosures in one place, with AI assistance to make complex filings easier to understand.
COCO reported insider sales of common stock by Corey Baker. The filing lists three dispositions of 2,000 shares each on 03/13/2026, 03/16/2026 and 03/17/2026 with reported proceeds of $117,720, $115,960 and $119,840 respectively. The form also records a prior grant/vesting of 2,000 shares (restricted stock vesting) dated 03/10/2025.
The Charles Schwab Corporation notice reports proposed sales of 11,700 shares of Common Stock by a selling party associated with stock compensation, filed on 03/18/2026.
Recent dispositions by the same selling party show three transactions during the prior three months: 3,900 shares on 01/21/2026, 3,900 shares on 02/18/2026, and 10,000 shares on 03/16/2026, with reported proceeds of $210,304.00, $216,991.00, and $601,369.00, respectively. The filing lists 57,082,173 shares (Common) with a reference date of 03/18/2026.
Vita Coco Company, Inc.’s Chief Financial Officer, Corey Baker, reported open‑market sales of 4,000 shares of common stock. The trades occurred on March 13, 2026 and March 16, 2026, with 2,000 shares sold at $58.86 and 2,000 shares at $57.98 per share.
After these transactions, Baker directly holds 31,951 shares of Vita Coco common stock. He also holds several non‑qualified stock options, including awards over 9,205 shares at $16.91 expiring on March 10, 2033 and 13,481 shares at $24.35 expiring on May 10, 2033. The sales were made under a pre‑arranged Rule 10b5‑1 trading plan.
Vita Coco Company, Inc. director Kenneth Sadowsky reported an open-market sale of 10,000 shares of common stock on March 16, 2026 at a weighted average price of $60.137 per share. The sale was effected under a pre-arranged Rule 10b5-1 trading plan.
After this transaction, Sadowsky directly holds 594,366 shares of Vita Coco common stock. He also holds a fully vested, currently exercisable non-qualified stock option covering 27,300 shares of common stock at an exercise price of $10.178 per share, expiring on January 2, 2030.
COCO filing indicates proposed sales of Common Stock by Corey Baker under Form 144. The filing lists two transactions of 2,000 shares each: one dated 03/13/2026 with an amount of 117,720.00, and one dated 03/16/2026 with an amount of 115,960.00.
The entries show the broker Fidelity Brokerage Services LLC and reference restricted stock vesting on 03/10/2025 for 2,000 shares. The filing is a notice of proposed resale by an affiliate; timing and final execution are not specified in the excerpt.
Fidelity Brokerage Services LLC filed a Form 144 reporting a proposed sale of Common stock. The notice lists 60,000 shares with an aggregate value of $3,519,200.00 and a baseline figure of 57,082,173 shares noted alongside the 03/16/2026 NASDAQ entry. The filing itemizes prior issuances and option/vesting events by date and share count.
COCO files a Rule 144 notice reporting proposed sale of Common Stock. The form lists broker Fidelity Brokerage Services LLC and a trade date of 03/16/2026 on NASDAQ. The excerpt shows restricted stock vesting entries of 1,531 shares (vested 11/27/2023) and 469 shares (vested 11/27/2024.
Corey Baker reported the sale of 2,000 shares of Common Stock. The filing shows 2,000 shares sold on 03/13/2026 for $117,720.00. The excerpt also records a prior restricted stock vesting of 2,000 shares on 03/10/2025.
Vita Coco Company, Inc. Executive Chairman Michael Kirban, through the Michael Kirban Revocable Trust, sold 50,000 shares of common stock in open-market transactions at $58 per share on March 11–12, 2026 under a Rule 10b5-1 trading plan. Following these sales, the filing shows continued indirect ownership of 565,681 shares in that trust, additional indirect holdings in the Michael Kirban 2010 Trust, direct ownership of common stock, and multiple fully vested and time-vesting stock options covering substantial additional shares.